Impact of dual antiplatelet therapy at different durations on the prognosis and safety of patients after percutaneous coronary intervention:a meta-analysis
|更新时间:2026-10-12
|
Impact of dual antiplatelet therapy at different durations on the prognosis and safety of patients after percutaneous coronary intervention:a meta-analysis
LUO Bing,JIANG Yueyun,CHEN Yili.Impact of dual antiplatelet therapy at different durations on the prognosis and safety of patients after percutaneous coronary intervention:a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(19):2582-2588.
LUO Bing,JIANG Yueyun,CHEN Yili.Impact of dual antiplatelet therapy at different durations on the prognosis and safety of patients after percutaneous coronary intervention:a meta-analysis[J].ZHONGGUO YAOFANG,2026,37(19):2582-2588.DOI: 10.6039/j.issn.1001-0408.2026.19.17.
Impact of dual antiplatelet therapy at different durations on the prognosis and safety of patients after percutaneous coronary intervention:a meta-analysis
Research progress on anticoagulant therapy in patients with liver cirrhosis complicated with portal vein thrombosis
Evaluation of the anticoagulant effect of nafamostat mesylate in continuous veno-venous hemofiltration with different dilution methods for uremic patients
放弃PCI术接受药物综合治疗的冠心病合并心力衰竭患者的预后分析
负荷量瑞舒伐他汀对非ST段抬高型急性冠脉综合征早期介入术后患者血管内皮功能的影响
PCI术前应用血塞通注射液对急性ST段抬高型心肌梗死患者相关指标的影响
Related Author
LI Yun
GONG Wei
ZHANG Yao
SHEN Li
WANG Jun
ZHU Hong
QIN Yong
TANG Yuewu
Related Institution
Dept. of Pharmacy, First Affiliated Hospital of Soochow University
Dept. of Pharmacy, Chongqing University Three Gorges Hospital
Dept. of Nephrology, Chongqing University Three Gorges Hospital